IBB
iShares Biotechnology ETF
Price Chart
Latest Quote
$181.53
+3.44 (+1.93%)
Current Price
| Previous Close | $178.09 |
| Open | $178.26 |
| Day High | $183.03 |
| Day Low | $178.26 |
| Volume | 2,588,556 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.23% |
| Shares Outstanding | 69.70M |
| Net Assets | $7.94B |
| Expense Ratio | 0.44% |
| Category | Health |
| Fund Family | iShares |
| Net Asset Value | $178.08 |
| Premium/Discount | 1.94% |
| Quarterly Dividend Yield | 0.23% |
| P/E Ratio | 23.50 |
| Exchange | NGM |
📊 ETF Analysis
Company Data
| Book/sh | $161.64 |
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
| P/B | 1.12 |
Analyst Data
Technical Indicators
| SMA20 | $171.28 |
| SMA50 | $170.84 |
| SMA200 | $165.56 |
| RSI | 72.38 |
| ATR | 4.0211 |
| Rel Volume | 1.78 |
Performance History
| Week | +5.89% |
| Month | +7.56% |
| Quarter | +12.32% |
| 6 Months | +6.75% |
| YTD | +7.51% |
| Year | +45.66% |
| 3 Years | +39.42% |
| 5 Years | +16.21% |
| 10 Years | +131.39% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-24 | $181.53 | 2,591,200 |
| 2026-06-23 | $178.09 | 1,621,400 |
| 2026-06-22 | $177.00 | 2,018,300 |
| 2026-06-18 | $173.64 | 998,900 |
| 2026-06-17 | $173.44 | 1,214,900 |
| 2026-06-16 | $171.44 | 1,029,100 |
| 2026-06-15 | $172.17 | 904,700 |
| 2026-06-12 | $170.64 | 1,706,900 |
| 2026-06-11 | $170.47 | 1,549,100 |
| 2026-06-10 | $165.91 | 1,272,100 |
| 2026-06-09 | $169.34 | 2,357,500 |
| 2026-06-08 | $166.90 | 995,900 |
| 2026-06-05 | $168.42 | 1,482,500 |
| 2026-06-04 | $171.41 | 1,470,300 |
| 2026-06-03 | $167.48 | 1,018,900 |
| 2026-06-02 | $164.25 | 1,965,000 |
| 2026-06-01 | $169.35 | 1,365,600 |
| 2026-05-29 | $172.16 | 1,406,900 |
| 2026-05-28 | $172.22 | 1,278,600 |
| 2026-05-27 | $169.86 | 823,200 |
| 2026-05-26 | $169.40 | 978,300 |
About iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
📰 Latest News
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid Easing US-Iran Tensions
MT Newswires • 2026-06-24T13:17:40ZZacks Investment Ideas feature highlights: IBB, Novartis, Pfizer and Eli Lilly's
Zacks • 2026-06-24T08:28:00Z
Biotech's Silent Resurgence (5-Year Base Breakout)
Zacks • 2026-06-23T20:17:00Z
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch.
MarketBeat • 2026-06-23T15:50:00Z
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as AI Spending Concerns Weigh on Technology Shares
MT Newswires • 2026-06-23T13:19:21ZExchange-Traded Funds, Equity Futures Higher Pre-Bell Amid Continued US-Iran Talks
MT Newswires • 2026-06-22T12:58:54ZShould You Invest in the iShares Biotechnology ETF (IBB)?
Zacks • 2026-06-22T10:20:02Z
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Interim US-Iran Deal Lifts Risk Sentiment
MT Newswires • 2026-06-18T12:57:23ZExchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Ahead of Fed Rates Announcement
MT Newswires • 2026-06-17T13:15:53ZExchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday Ahead of Fed Policy Meeting
MT Newswires • 2026-06-16T12:34:51Z
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.